Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a sensitive and specific quantitative reverse transcription-polymerase chain reaction assay for blood thyroglobulin messenger ribonucleic acid in the follow-up of patients with differentiated thyroid carcinoma.
Boldarine VT, Maciel RM, Guimarães GS, Nakabashi CC, Camacho CP, Andreoni DM, Mamone Mda C, Ikejiri ES, Kasamatsu TS, Crispim F, Hojaij FC, Hidal JT, Biscolla RP. Boldarine VT, et al. Among authors: nakabashi cc. J Clin Endocrinol Metab. 2010 Apr;95(4):1726-33. doi: 10.1210/jc.2009-1354. Epub 2010 Feb 19. J Clin Endocrinol Metab. 2010. PMID: 20173019
Clinical impact of thyroglobulin (Tg) and Tg autoantibody (TgAb) measurements in needle washouts of neck lymph node biopsies in the management of patients with papillary thyroid carcinoma.
Martins-Costa MC, Maciel RMB, Kasamatsu TS, Nakabashi CCD, Camacho CP, Crispim F, Ikejiri ES, Mamone MCO, Andreoni DM, Biscolla RPM. Martins-Costa MC, et al. Among authors: nakabashi ccd. Arch Endocrinol Metab. 2017 Mar-Apr;61(2):108-114. doi: 10.1590/2359-3997000000241. Epub 2017 Feb 13. Arch Endocrinol Metab. 2017. PMID: 28225995 Free PMC article.
Clinical utility of 18F-FDG PET/CT in the follow-up of a large cohort of patients with high-risk differentiated thyroid carcinoma.
Yang JH, Maciel RMB, Nakabashi CCD, Janovsky CCPS, Padovani RP, Macellaro D, Camacho CP, Osawa A, Wagner J, Biscolla RPM. Yang JH, et al. Among authors: nakabashi ccd. Arch Endocrinol Metab. 2017 Sept-Oct;61(5):416-425. doi: 10.1590/2359-3997000000285. Epub 2017 Sep 18. Arch Endocrinol Metab. 2017. PMID: 28977157 Free PMC article.
[Diagnosis of metastases in patients with papillary thyroid cancer by the measurement of thyroglobulin in fine needle aspirate].
Biscolla RP, Ikejiri ES, Mamone MC, Nakabashi CC, Andrade VP, Kasamatsu TS, Crispim F, Chiamolera MI, Andreoni DM, Camacho CP, Hojaij FC, Vieira JG, Furlanetto RP, Maciel RM. Biscolla RP, et al. Among authors: nakabashi cc. Arq Bras Endocrinol Metabol. 2007 Apr;51(3):419-25. doi: 10.1590/s0004-27302007000300009. Arq Bras Endocrinol Metabol. 2007. PMID: 17546240 Portuguese.
One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy.
Padovani RP, Kasamatsu TS, Nakabashi CC, Camacho CP, Andreoni DM, Malouf EZ, Marone MM, Maciel RM, Biscolla RP. Padovani RP, et al. Among authors: nakabashi cc. Thyroid. 2012 Sep;22(9):926-30. doi: 10.1089/thy.2012.0099. Epub 2012 Jul 24. Thyroid. 2012. PMID: 22827435 Free PMC article.
Basal serum thyroglobulin measured by a second-generation assay is equivalent to stimulated thyroglobulin in identifying metastases in patients with differentiated thyroid cancer with low or intermediate risk of recurrence.
Nakabashi CC, Kasamatsu TS, Crispim F, Yamazaki CA, Camacho CP, Andreoni DM, Padovani RP, Ikejiri ES, Mamone MC, Aldighieri FC, Wagner J, Hidal JT, Vieira JG, Biscolla RP, Maciel RM. Nakabashi CC, et al. Eur Thyroid J. 2014 Mar;3(1):43-50. doi: 10.1159/000360077. Epub 2014 Mar 12. Eur Thyroid J. 2014. PMID: 24847465 Free PMC article.
The role of a new polyclonal competitive thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer with structural disease but low levels of serum thyroglobulin by immunometric and LC-MS/MS methods.
Guastapaglia L, Kasamatsu TS, Nakabashi CCD, Camacho CP, Maciel RMB, Vieira JGH, Biscolla RPM. Guastapaglia L, et al. Among authors: nakabashi ccd. Endocrine. 2021 Jun;72(3):784-790. doi: 10.1007/s12020-020-02526-8. Epub 2020 Nov 22. Endocrine. 2021. PMID: 33222120
12 results